New Retina Radio by Eyetube
By Eyetube
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Eyetube
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 11
Reviews: 0
Episodes: 165
Description
New Retina Radio is a place to hear stories about retina that are told nowhere else.
| Episode | Date |
|---|---|
|
GA Options in Clinical Therapy, Part 2: Real-world Cases in GA
|
May 10, 2024 |
|
GA Options in Clinical Therapy, Part 1: Patient Selection and Treatment Strategies
|
May 10, 2024 |
|
AMD and DME Applications in the Retina Practice: RCT Comparison
|
May 08, 2024 |
|
The State of Biosimilars: Integration of Biosimilars into a Retina Practice
|
Apr 25, 2024 |
|
New Retina Radio Journal Club with VBS: Comparison of Antiseptics Use for IVT
|
Apr 19, 2024 |
|
Successful Management of Vitreous Opacities
|
Apr 02, 2024 |
|
New Retina Radio Journal Club with VBS: Visual Outcomes Following Surgical RRD Repair Relative to Foveal Status and Time of Surgery
|
Mar 28, 2024 |
|
Treating Geographic Atrophy (GA) In Your Practice
|
Mar 01, 2024 |
|
Diagnosing Geographic Atrophy (GA) and Identifying Eligible Patients For Therapy
|
Mar 01, 2024 |
|
The State of Biosimilars: How We Got Here and What It Means for Practice
|
Feb 22, 2024 |
|
Cherchez la Femme Revisited
|
Feb 16, 2024 |
|
AAO ’23: Downward Trends in Reimbursement and ChatGPT in the Retina Clinic
|
Dec 14, 2023 |
|
New Retina Radio Journal Club: Intentional Suspension of Therapy in Wet AMD
|
Dec 07, 2023 |
|
AAO ’23: Real-World Faricimab Patterns and Improving GA Assessments
|
Nov 30, 2023 |
|
New Retina Radio AAO Late-Breakers: PULSAR at 96 Weeks and Home OCT in Wet AMD
|
Nov 22, 2023 |
|
New Retina Radio Journal Club: Prophylactic Laser for Lattice Degeneration in Fellow Eyes After RRD Repair
|
Nov 21, 2023 |
|
New Retina Radio AAO Late-Breakers: ALTITUDE and DIAMOND
|
Nov 13, 2023 |
|
New Retina Radio Journal Club: Are Postpartum Retinal Detachment Rates Linked to Method of Delivery?
|
Oct 26, 2023 |
|
Chronic Postoperative Inflammation: Patient Scenarios
|
Oct 05, 2023 |
|
New Retina Radio Journal Club: Cost Evaluation in DME Therapy
|
Sep 28, 2023 |
|
How Imaging Helps Clinics Integrate New Therapies in GA
|
Sep 25, 2023 |
|
Luminaries in Retina: Kirk Packo, MD, FACS (Part 2)
|
Sep 22, 2023 |
|
Luminaries in Retina: Kirk Packo, MD, FACS (Part 1)
|
Sep 22, 2023 |
|
Chronic Postoperative Inflammation: Steroids’ Role in Treatment
|
Sep 21, 2023 |
|
New Retina Radio Journal Club: Meta-analysis of PPV for Diabetic TRD
|
Sep 07, 2023 |
|
ASRS ’23: Pegcetacoplan Extension Study, and Comparison of Pegcetacoplan and Avacincaptad Pegol
|
Sep 01, 2023 |
|
Chronic Postoperative Inflammation: Initial Encounters
|
Aug 25, 2023 |
|
Imaging Geographic Atrophy: OCT, FAF, NIR, and OCTA
|
Aug 22, 2023 |
|
ASRS ’23: Missed Injections for AMD/DME/RVO and Anatomic Response to Vabysmo in Wet AMD
|
Aug 11, 2023 |
|
New Retina Radio Journal Club: Is Software on Home OCT as Good as Human Graders?
|
Jul 20, 2023 |
|
New Retina Radio Journal Club: Wet AMD: Fluid-free Visits' Association with Anatomic and Visual Outcomes
|
May 25, 2023 |
|
New Retina Radio ARVO Coverage: DME Update: 8-mg Aflibercept data and Faricimab TAE in Phase 3
|
May 18, 2023 |
|
New Retina Radio ARVO Coverage: Faricimab in Wet AMD: Real-world and Phase 3 Data
|
May 11, 2023 |
|
Treating GA In Your Clinic
|
May 03, 2023 |
|
New Retina Radio Journal Club: AMD and Depression Risk
|
Apr 20, 2023 |
|
New Retina Radio Journal Club: Duration of Macular Detachment and Final Visual Prognosis
|
Mar 28, 2023 |
|
The Utility of OCTA in the Clinic
|
Mar 27, 2023 |
|
The Era of Geographic Atrophy Treatment Begins
|
Feb 23, 2023 |
|
Inclusion Pearls and Pitfalls For Retina Specialists
|
Feb 13, 2023 |
|
Tips for Mastering Secondary IOLs
|
Dec 29, 2022 |
|
New Retina Radio Journal Club: Profiling Punctate Inner Choroidopathy-like Reactions
|
Dec 15, 2022 |
|
AAO '22: Biosimilars’ Practice Implications and Year 2 of YOSEMITE/RHINE
|
Dec 09, 2022 |
|
Innovations in Retinal Imaging
|
Dec 05, 2022 |
|
AAO '22 Late-Breaking Talks: Gene Therapies for GA and XLRP
|
Dec 01, 2022 |
|
New Retina Radio Journal Club: Biosimilars in Retina: A Pair of Phase 3 Papers
|
Nov 17, 2022 |
|
AAO '22: Biomarkers and AI in the OR
|
Nov 10, 2022 |
|
AAO '22 Late-Breaking Talks: Biosimilar Phase 3 Data and TRUCKEE Update
|
Nov 03, 2022 |
|
AAO '22: GATHER2 Study Results
|
Oct 25, 2022 |
|
New Retina Radio Journal Club: Latest Literature in Stickler Syndrome and GRTs
|
Oct 13, 2022 |
|
New Retina Radio Journal Club: Updates in ROP
|
Sep 30, 2022 |
|
ASRS Meeting Coverage Day 3: DR Biomarkers and Gene Tx for Achromatopsia
|
Sep 15, 2022 |
|
New Retina Radio Journal Club: Multifocal, Indolent, Nonprogressive Choroidal Lesions
|
Aug 25, 2022 |
|
ASRS Meeting Coverage: Day 2
|
Aug 04, 2022 |
|
ASRS Meeting Coverage: Day 1
|
Jul 28, 2022 |
|
New Retina Radio Journal Club: Recurrent RRD Management
|
Jul 14, 2022 |
|
The Life and Career of Steve Charles, MD, FACS, FICS, FASRS
|
Jun 30, 2022 |
|
New Retina Radio Journal Club: Pentosan Polysulfate Maculopathy
|
Jun 23, 2022 |
|
ARVO Meeting Coverage Day 3: CANDELA and ARCHWAY Data
|
Jun 09, 2022 |
|
ARVO Meeting Coverage Day 2: Pipeline Therapies in GA
|
Jun 02, 2022 |
|
ARVO Meeting Coverage Day 1: LIGHTSITE III and DERBY/OAKS at 18 Months
|
May 26, 2022 |
|
New Treatment Options and Considerations for AMD
|
May 19, 2022 |
|
New Retina Radio Journal Club: Trends in Retina Reimbursement
|
May 12, 2022 |
|
New Retina Radio Journal Club: Diversity in Clinical Trials
|
Apr 21, 2022 |
|
New Retina Radio Journal Club: PPV vs PnR for RRD
|
Mar 31, 2022 |
|
Art of Drug Choice: Treating New Wet AMD Patients
|
Mar 24, 2022 |
|
Art of Drug Choice: Who Is Best Suited for Extended-duration Therapy?
|
Mar 17, 2022 |
|
Art of Drug Choice: The Latest Advances in Wet AMD Therapy
|
Mar 03, 2022 |
|
Anti-VEGF, A Biography: Part 3
|
Feb 24, 2022 |
|
Anti-VEGF, A Biography: Part 2
|
Feb 17, 2022 |
|
Exploring the clinical development program for an innovative, continuous delivery treatment for nAMD
|
Feb 11, 2022 |
|
Tackling PVR in the OR
|
Feb 03, 2022 |
|
Anti-VEGF, A Biography: Part 1
|
Jan 27, 2022 |
|
Perspectives on an innovative drug delivery system for nAMD: From training to initial experiences
|
Jan 18, 2022 |
|
Matching Patients to Therapy in Wet AMD: Lifestyle Factors That Guide Treatment
|
Jan 04, 2022 |
|
Matching Patients to Therapy in Wet AMD: Deciding Who Is Best Suited for Long-Duration Treatments
|
Dec 22, 2021 |
|
AAO 2021: Updates in Uveitis and Trauma
|
Dec 17, 2021 |
|
Matching Patients to Therapy in Wet AMD: How New Technology May Alleviate Treatment Burden
|
Dec 14, 2021 |
|
New Retina Radio Journal Club: Medical Management of Macular Holes
|
Dec 10, 2021 |
|
The Latest on Gene Therapy for Inherited Retinal Diseases
|
Dec 07, 2021 |
|
AAO 2021: PALADIN for DME and ROP Updates From the ICROP
|
Dec 03, 2021 |
|
AAO 2021 Late Breakers: DAVIO and NORSE-2
|
Nov 30, 2021 |
|
New Retina Radio Journal Club: Biosimilars in Wet AMD
|
Nov 26, 2021 |
|
AAO 2021: Protocol W and Monitoring for Wet AMD
|
Nov 23, 2021 |
|
AAO 2021 Late Breakers: GATHER1 and ALTISSIMO
|
Nov 19, 2021 |
|
Developing an innovative drug delivery system for nAMD
|
Nov 16, 2021 |
|
International Perspectives on ROP
|
Nov 12, 2021 |
|
Luminaries in Retina: Kirk Packo, MD, FACS (Part 2)
|
Nov 09, 2021 |
|
Luminaries in Retina: Kirk Packo, MD, FACS (Part 1)
|
Nov 09, 2021 |
|
ASRS 2021: The Pipeline for Wet AMD and GA
|
Nov 05, 2021 |
|
ASRS 2021: Losing GA Patients to Follow-up and DME Meta-analysis
|
Oct 29, 2021 |
|
ASRS 2021: ARCHWAY and TENAYA/LUCERNE
|
Oct 22, 2021 |
|
Vitreous Opacities: How ODs and MDs Can Collaborate
|
Oct 19, 2021 |
|
New Retina Radio Journal Club: Treating CMV with Adoptive Immunotherapy
|
Oct 15, 2021 |
|
International Perspectives: RVO
|
Oct 08, 2021 |
|
Vitreous Opacities: Hearing from Anterior and Posterior Segment Surgeons
|
Oct 01, 2021 |
|
New Retina Radio Journal Club: Exudative AMD in FILLY and GATHER1 Results
|
Sep 17, 2021 |
|
The Art of Drug Choice: International Panel in Wet AMD: Safety Data
|
Sep 10, 2021 |
|
Vitreous Opacities: Innovations and the Decision to Operate
|
Sep 03, 2021 |
|
The Art of Drug Choice: International Panel in Wet AMD: The Pipeline
|
Sep 01, 2021 |
|
International Perspectives: DME
|
Aug 27, 2021 |
|
The Art of Drug Choice: International Panel in Wet AMD: Phase 3 and Real-World Data to Watch
|
Aug 20, 2021 |
|
New Retina Radio Journal Club: Data in the Wake of COVID-19
|
Aug 13, 2021 |
|
The Art of Drug Choice: International Panel in Wet AMD: When and Why Switching Therapy Makes Sense
|
Aug 06, 2021 |
|
Surgical options for treating AMD: Clinical Implications and Impact
|
Jul 29, 2021 |
|
Advances in Gene Therapy for Wet AMD
|
Jul 26, 2021 |
|
New Retina Radio Journal Club: Masking in Retina: Keeping Patients Safe from Bacterial Exposure
|
Jul 16, 2021 |
|
Reconsidering treatment endpoints in real-world clinical practice: is achieving a favorable retreatment interval a goal of therapy?
|
Jul 09, 2021 |
|
New Retina Radio Journal Club: Autologous Retina Transplant for Macular Holes
|
Jun 25, 2021 |
|
Real-world impact of patients lost to follow-up: factors that drive nonadherence and strategies for encouraging better follow-up from patients
|
Jun 11, 2021 |
|
ARVO 2021 Coverage: NGM621 and COOG2
|
Jun 04, 2021 |
|
ARVO 2021: GATHER1 Study and CME After RRD Surgery
|
May 28, 2021 |
|
ARVO 2021 Coverage: TENAYA/LUCERNE Results—and Is Fluid OK in Wet AMD?
|
May 21, 2021 |
|
New Retina Radio Journal Club: Protocol W: How Might the Data Change Practice?
|
May 14, 2021 |
|
New Retina Radio Journal Club: PRO Study Group Papers: Part 2
|
Apr 15, 2021 |
|
New Retina Radio Journal Club: PRO Study Group Papers: Part 1
|
Mar 30, 2021 |
|
Angiogenesis 2021: Early Phase Data
|
Mar 23, 2021 |
|
Angiogenesis 2021: Wet AMD
|
Mar 12, 2021 |
|
New Retina Radio Journal Club: OCT Biomarkers in New Onset GA
|
Mar 08, 2021 |
|
Angiogenesis 2021: Geographic Atrophy
|
Mar 04, 2021 |
|
Let’s Talk Diversity and Inclusion
|
Mar 01, 2021 |
|
New Retina Radio Journal Club: Anti-VEGF vs Surgery + PRP for VH with PDR
|
Feb 25, 2021 |
|
New Retina Radio Journal Club: Phase 2 LADDER Study Data
|
Feb 10, 2021 |
|
International Perspectives: Digital Solutions for the Management of Amblyopia
|
Feb 08, 2021 |
|
International Perspectives: How Will Artificial Intelligence Affect the Practice of Ophthalmology?
|
Jan 28, 2021 |
|
Clinical Impacts From AAO 2020: Drs. Singh, Ehlers, and Gillies
|
Jan 25, 2021 |
|
Fluid in Neovascular Age-Related Macular Degeneration – Evolution of Understanding
|
Jan 20, 2021 |
|
New Retina Radio Journal Club: Imaging Modalities in DR
|
Jan 08, 2021 |
|
New Retina Radio Journal Club: Intravitreal Dexamethasone Implant in DME Patients
|
Dec 21, 2020 |
|
Clinical Impacts From AAO 2020: Drs. Singh, Do, and Heier
|
Dec 17, 2020 |
|
DRCR Retina Network Protocol AB at AAO
|
Dec 07, 2020 |
|
AAO Late Breaker: IRIS Registry Data on GA
|
Dec 02, 2020 |
|
Coding Changes for 2021 at AAO
|
Nov 30, 2020 |
|
AAO Late Breaker: Ang-2 Mediation in DME Therapy
|
Nov 25, 2020 |
|
Retinal Arteriolar Macroaneurysm and Anti-VEGF Therapy at AAO
|
Nov 23, 2020 |
|
AAO Late Breaker: KSI-301 in DME Therapy
|
Nov 20, 2020 |
|
The Art of Drug Choice: Safety in Wet AMD
|
Nov 19, 2020 |
|
The Art of Drug Choice: Wet AMD Pipeline
|
Nov 19, 2020 |
|
The Art of Drug Choice: Phase 3 Trials in Wet AMD
|
Nov 19, 2020 |
|
The Art of Drug Choice: Wet AMD and the Latest Data [Miniseries]
|
Nov 19, 2020 |
|
ARCHWAY at AAO
|
Nov 18, 2020 |
|
New Retina Radio Journal Club: Putting the Fun Back in Journal Club
|
Nov 10, 2020 |
|
Clinical considerations for optimal management of patients with IRDs
|
Oct 30, 2020 |
|
[Back to Practice] Combating Patient Misinformation Regarding COVID-19
|
Oct 16, 2020 |
|
[Back to Practice] Telemedicine & Combating Patient Misinformation
|
Oct 15, 2020 |
|
[Back to Practice] Telemedicine in the COVID-19 Era
|
Oct 03, 2020 |
|
[Back to Practice] Academic Settings in a Pandemic: Rules and Regulations
|
Oct 01, 2020 |
|
[Back to Practice] Educating the Next Generation of Surgeons During COVID-19
|
Sep 16, 2020 |
|
jCell Therapy for Retinitis Pigmentosa and Phase 2B Data
|
Aug 31, 2020 |
|
[Back to Practice] What Happens During a COVID-19 Resurgence?
|
Aug 28, 2020 |
|
[Back to Practice] Technology and COVID-19: Necessity Is the Mother of Invention
|
Aug 26, 2020 |
|
Treat-and-Extend in the Real World
|
Aug 21, 2020 |
|
Opioid Prescribing Patterns Among Retina Specialists
|
Aug 12, 2020 |
|
Continuous Dosing in LADDER
|
Aug 04, 2020 |
|
[Back to Practice] COVID-19 Clinical and Surgical Protocols: Which Changes Are Here to Stay?
|
Aug 03, 2020 |
|
[Back to Practice] Education as In-Person Meetings Are Paused
|
Jul 30, 2020 |
|
Faricimab in Phase 2 and 3
|
Jun 30, 2020 |
|
Anti-VEGF, A Biography: Part 3
|
Jun 15, 2018 |
|
Anti-VEGF, A Biography: Part 2
|
Nov 22, 2017 |
|
Beyond the Walls of ORs and Borders of Nations
|
Aug 28, 2017 |
|
Retina Is for the Birds
|
Jun 14, 2017 |
|
Anti-VEGF, A Biography: Part 1
|
Apr 24, 2017 |
|
Alphabet Soup: PhD, MBA, JD, MS
|
Feb 24, 2017 |
|
The Dating Game
|
Jan 23, 2017 |
|
Je Ne Sais Quoi
|
Dec 28, 2016 |
|
Ophthalmologist Barbie
|
Nov 16, 2016 |